Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Rom J Morphol Embryol ; 63(1): 203-207, 2022.
Article in English | MEDLINE | ID: mdl-36074685

ABSTRACT

Sacrococcygeal teratomas (SCTs) are rare congenital tumors. With the improvement of diagnostic imaging methods and follow-up protocols in pregnancies, in utero detection of these tumors has increased. Despite these progresses, SCTs may present difficulties in establishing in utero diagnosis and subsequent management. We present two cases of SCT in 18 weeks, respectively 22 weeks pregnancy, diagnosed using ultrasound imaging and pathologically confirmed. Also, the article aims to recapitulate clinicopathological aspects and prognosis of these lesions, following the review of the literature.


Subject(s)
Pelvic Neoplasms , Spinal Neoplasms , Teratoma , Female , Gestational Age , Humans , Pregnancy , Prenatal Diagnosis , Sacrococcygeal Region/pathology , Teratoma/diagnostic imaging , Ultrasonography, Prenatal
2.
Rom J Morphol Embryol ; 59(2): 527-531, 2018.
Article in English | MEDLINE | ID: mdl-30173258

ABSTRACT

The prevalence of endometrial cancer among asymptomatic women is rather reduced also due to the absence of a cost-efficient test, as there are no ideal screening examinations for endometrial cancer. Several methods were proposed in medical practice to discover endometrial neoplasia at an early stage, among which: endometrial biopsy, endovaginal ultrasound, targeted biopsy hysteroscopy. This study was made on a group of 38 patients monitored for metrorrhagia in the interval between July 1, 2014-July 1, 2016. All patients were monitored clinically and by ultrasound, endometrium samples were taken by biopsied uterine curettage, and a histopathological examination was performed, completed by immunomarking, whenever necessary. The clinical and paraclinical methods allowed for the creation of a protocol by which patients were monitored. This protocol allowed for the modulation and effectiveness of the treatment, establishing the best therapeutic conduct and the remote supervision.


Subject(s)
Endometrial Neoplasms/diagnosis , Adult , Aged , Early Detection of Cancer , Endometrial Neoplasms/pathology , Female , Humans , Mass Screening , Middle Aged
3.
Rom J Morphol Embryol ; 59(4): 1233-1237, 2018.
Article in English | MEDLINE | ID: mdl-30845306

ABSTRACT

Clear cell carcinoma (CCC) of the female genital tract usually arises in the ovary, endometrium, cervix and vagina. A rare site for CCC is the vulva, and moreover even rarer are the cases involving the Bartholin gland. A 54-year-old female was admitted for a 1.5×2 cm tumor at the level of the right Bartholin gland. The magnetic resonance imaging (MRI) exam revealed enlarged inguinal, pelvic and para-aortic lymph nodes but no other primary tumor. Microscopic examination revealed CCC. The tumor was positive for cytokeratin 7 (CK7), paired-box 8 (Pax8), napsin A and vimentin, negative for estrogen receptor (ER), progesterone receptor (PR), calretinin, cluster of differentiation 10 (CD10), carcinoembryonic antigen (CEA), p16 and p63. Also, p53 was expressed in 30-40% and Ki67 in 70% of the malignant cells. Given the clinical, imagistic, histological and immunohistochemical features of the tumor, we concluded that the tumor is a CCC of the Bartholin gland. Aim of the study is to signal a rare case of CCC of Bartholin gland. Since there are only two other cases reported in literature, the natural history and prognosis of the disease is not known, also there are no therapeutic guidelines regarding this rare tumor so appropriate treatment is uncertain. Therefore, it is important that new cases are reported for a better understanding of this rare condition. Bartholin gland carcinoma is a pathology quite rarely encountered in practice. The positive diagnosis is eminently histological and immunohistochemistry. Bartholin gland CCC is an extremely rare diagnosis with, to our knowledge, only two other cases reported in literature, but with a potential aggressive clinical behavior and poor outcome.


Subject(s)
Adenocarcinoma, Clear Cell/diagnosis , Adenocarcinoma, Clear Cell/pathology , Vulvar Neoplasms/diagnosis , Vulvar Neoplasms/pathology , Adenocarcinoma, Clear Cell/diagnostic imaging , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Vulvar Neoplasms/diagnostic imaging
4.
Rom J Morphol Embryol ; 58(4): 1157-1164, 2017.
Article in English | MEDLINE | ID: mdl-29556604

ABSTRACT

Isolated splenic metastases from squamous cell carcinoma (SCC) of the cervix are rare, with few cases reported in the literature. We review here the main clinical and pathological findings in these patients, with emphasis on histopathological features. Because they are so rare, complex follow-up protocols for patients diagnosed with cervical SCC should exist because, if detected and treated, solitary splenic metastases seem to have a better prognosis than splenic metastases as part of a disseminated disease.


Subject(s)
Splenic Neoplasms/secondary , Uterine Cervical Neoplasms/complications , Adult , Carcinoma, Squamous Cell/pathology , Female , Humans , Middle Aged , Neoplasm Metastasis , Splenic Neoplasms/pathology , Uterine Cervical Neoplasms/pathology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...